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Segregation of a latent high adiposity phenotype in families with a history
of type 2 diabetes mellitus implicates rare obesity-susceptibility genetic
variants with large effects in diabetes-related obesity
Abstract
Background We recently reported significantly greater weight gain in non-diabetic healthy subjects with a 1st
degree family history (FH+) of type 2 diabetes mellitus (T2DM) than in a matched control group without
such history (FH−) during voluntary overfeeding, implying co-inheritance of susceptibilities to T2DM and
obesity. We have estimated the extent and mode of inheritance of susceptibility to increased adiposity in FH+.
Methods Normoglycaemic participants were categorised either FH+ (≥1 1st degree relative with T2DM,
50F/30M, age 45±14 (SD) yr) or FH− (71F/51M, age 43±14 yr). Log-transformed anthropometric
measurements (height, hip and waist circumferences) and lean, bone and fat mass (Dual Energy X-ray
Absorptiometry) data were analysed by rotated Factor Analysis. The age- and gender-adjusted distributions of
indices of adiposity in FH+ were assessed by fits to a bimodal model and by relative risk ratios (RR,
FH+/FH−) and interpreted in a purely genetic model of FH effects.
Results The two orthogonal factors extracted, interpretable as Frame and Adiposity accounted for 80% of the
variance in the input data. FH+ was associated with significantly higher Adiposity scores (p
Conclusions The segregation of Adiposity in T2DM-affected families is consistent with dominant expression
of rare risk variants with major effects, which are expressed in over half of FH+ and which can account for
most T2DM-associated obesity in our population. The calculated risk allele frequency in FH− suggests that
rare genetic variants could also account for a substantial fraction of the prevalent obesity in this society.
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Families with a History of Type 2 Diabetes Mellitus
Implicates Rare Obesity-Susceptibility Genetic Variants
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Abstract
Background: We recently reported significantly greater weight gain in non-diabetic healthy subjects with a 1st degree
family history (FH+) of type 2 diabetes mellitus (T2DM) than in a matched control group without such history (FH2) during
voluntary overfeeding, implying co-inheritance of susceptibilities to T2DM and obesity. We have estimated the extent and
mode of inheritance of susceptibility to increased adiposity in FH+.
Methods: Normoglycaemic participants were categorised either FH+ ($1 1st degree relative with T2DM, 50F/30M, age
45614 (SD) yr) or FH2 (71F/51M, age 43614 yr). Log-transformed anthropometric measurements (height, hip and waist
circumferences) and lean, bone and fat mass (Dual Energy X-ray Absorptiometry) data were analysed by rotated Factor
Analysis. The age- and gender-adjusted distributions of indices of adiposity in FH+ were assessed by fits to a bimodal model
and by relative risk ratios (RR, FH+/FH2) and interpreted in a purely genetic model of FH effects.
Results: The two orthogonal factors extracted, interpretable as Frame and Adiposity accounted for 80% of the variance in
the input data. FH+ was associated with significantly higher Adiposity scores (p,0.01) without affecting Frame scores.
Adiposity scores in FH+ conformed to a bimodal normal distribution, consistent with dominant expression of major
susceptibility genes with 59% (95% CI 40%, 74%) of individuals under the higher mode. Calculated risk allele frequencies
were 0.09 (0.02, 0.23) in FH2, 0.36 (0.22, 0.48) in FH+ and 0.62 (0.36, 0.88) in unobserved T2DM-affected family members.
Conclusions: The segregation of Adiposity in T2DM-affected families is consistent with dominant expression of rare risk
variants with major effects, which are expressed in over half of FH+ and which can account for most T2DM-associated
obesity in our population. The calculated risk allele frequency in FH2 suggests that rare genetic variants could also account
for a substantial fraction of the prevalent obesity in this society.
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Introduction
Type 2 diabetes mellitus (T2DM) is a growing worldwide public
and individual health burden, linked to a similar increase in
overweight and obesity [1], which is present in 80–90% of T2DM
[2]. Increased adiposity and T2DM are both under strong genetic
influences but the precise links, genetic and otherwise, between the
two conditions are not clarified [3]. The known common single
nucleotide variants (SNVs) account for small fractions of the total
genetic susceptibilities to increased adiposity (,5%) and T2DM
(,10%) [4]. The much-sought cause(s) of the missing heritability
in genome-wide association studies (GWAS) is unclear but possible
contributors include small effect sizes, copy number variants
(CNVs), rare variants, gene-gene and gene-environment interac-
tions and poor definitions of phenotypes in GWAS [5].
Reports of higher BMI in individuals with a family history of
T2DM [6,7] imply that susceptibilities to increased adiposity and
to T2DM are co-transmitted in families. Recently, we showed that
healthy non-diabetic subjects with a family history of T2DM
gained significantly more weight than a matched control group
without a family history during a month-long voluntary overfeed-
ing protocol [8]. We then aimed to test, in a similar healthy but
larger group, if family history of T2DM has an effect on accurately
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measured body composition consistent with co-transmission of the
two traits.
The known genetic components of both T2DM and increased
adiposity are highly heterogeneous [9] and are often characterised
as polygenic in nature, where individual genetic susceptibility to
the disorder is a result of the combined actions of multiple
susceptibility variants at different loci [10]. Under those conditions
transmission of susceptibility will not follow simple Mendelian
patterns. Association studies are not powered to detect the
predicted interactions between multiple loci. Recent evidence
indicates that most of the variation in the human genome is rare
and therefore below detection threshold for association studies
[11–14]. This raises the strong possibility that many complex
disorders have a heterogenetic basis in which individual genetic
susceptibility is strongly determined by a single rare variant which
would often differ between unrelated individuals [15]. While both
heterogenetic and polygenetic mechanisms could explain the
minor fraction of overall genetic susceptibility currently detected
by genomic studies [4], they differ in prediction regarding
segregation analyses. Importantly, in contrast to polygenetic causal
variants, a single locus heterogenetic model predicts Mendelian
segregation of susceptibility within families [5].
Genetically complex disorders like increased adiposity and
T2DM may also be phenotypically complex but usually the choice
of phenotypic markers for expensive large scale genetic studies is
based on logistic considerations alone. Simplistic clinical manage-
ment phenotypes do not adequately represent the genetic
underpinnings of these disorders and hence contribute to the
apparent complexity of the current picture [5,16]. The concept of
increased adiposity appears intuitively simple, but in humans is not
easy to define or measure accurately. Most genetic studies of
adiposity use the surrogate BMI, despite its well-recognised
limitations as a measurement of true adiposity [16–18], because
potentially more informative measures have been impractical for
large samples. Similar limitations also apply to common anthro-
pometric indices involving waist and hip circumferences. More
direct measures of body fat content have been used in some studies
(e.g. Pecioska et al. [19]), but it is not clear a priori how to express
these measures as a biologically meaningful index of increased
adiposity. The common clinical usage of percent body fat cut-offs
is arbitrary [20] and analysing continuous measures like percent
body fat or fat mass indices implies assumptions about how
adiposity affects or is affected by disease processes. The use of
either BMI or percent body fat as covariates can lead to erroneous
conclusions in a genetic context [21].
A less arbitrary approach is the use of factor analysis, a statistical
technique that extracts a small number of latent (unmeasured)
factors that account for the correlations between multiple related
variables. Our data, consisting of direct measures of fat, lean and
bone masses as well as anthropometric measures (height, waist and
hip circumferences) are well suited to factor analysis. We have
extracted from our data a factor interpretable as Adiposity and
analysed its relationship to family history of T2DM in a model
which allows discrimination between polygenetic and heteroge-
netic modes of inheritance.
Methods
Ethics Statement
The studies were approved by the Human Research and Ethics
Committee of St Vincent’s Hospital, Sydney. All participants
provided written informed consent.
Recruitment, Selection and Matching
Participants (n = 202) were recruited, by advertisements in
newspapers and around the St. Vincent’s Hospital Sydney
campus, into studies conducted over the period 1994–2010 at
the Garvan Institute [8,22–25]. Participants with one or more first
degree relatives diagnosed with T2DM were categorised FH+.
Within studies, FH+ and FH2 participants were matched for
gender, age and BMI. In the combined sample, gender- and age-
matching were preserved with borderline matching of BMI
(Table 1). Subjects were excluded if weight had changed
substantially in the preceding 3 to 6 months, if they exercised
more than 60 min per week, if they were taking medications
known to affect insulin sensitivity or if they had a personal history
of T2DM. Our data set consists of de-identified data from all
participants for whom complete birth date, gender, body
composition, anthropometry and FH data were available as of
29/10/2010.
Measurements
Anthropometry. Weight and height were measured in light
clothing with footwear removed. Body mass index (BMI) was
calculated as weight divided by height squared (kg/m2). With the
subject standing, waist circumference at the level of the umbilicus
and hip circumference at the level of the greater trochanter were
measured to the nearest 0.5 cm using a flexible tape.
Body composition. Fat mass, lean mass and bone mass were
assessed by Dual Energy X-ray Absorptiometry (DXA; Lunar
DPX-Lunar Radiation V1.3y-1.35y, Madison, WI, USA).
Data Analysis
Model. The model of family history that we use is based on
the classic ADCE model for twin data, where total trait variance is
partitioned into either additive or dominant genetic (A or D) and
Table 1. Effects of family history of T2DM (FH+/2) on
anthropometric and body composition variables.
Groupa FH effectb
Variable FH+ FH2 Unadjusted Adjustedc
Gender (F/M) 50/30 71/51 0.54 –
Age (y) 45614 43614 0.34 –
Height (m) 1.6960.10 1.7060.10 0.72 0.81
Waist (cm) 89613 85615 0.06 0.01
Hip (cm) 10369 101611 0.05 0.06
Body weight (kg) 76615 74617 0.25 0.12
Lean mass (kg) 47611 47611 0.61 0.99
Bone mass (kg) 2.860.5 2.860.5 0.47 0.11
Fat mass (kg) 27610 24612 0.04 0.05
BMI (kg/m2) 26.764.5 25.565.3 0.06 0.06
Normal/O’weight
/Obesed (%)
38/40/23 55/30/15 0.05 –
Body fat (%) 35.369.6 31.5610.5 0.01 0.01
Frame (SD units) 20.0761.00 0.0561.01 0.41 0.57
Adiposity (SD units) 0.2560.88 20.1661.09 0.01 0.01
aMean 6 SD except for Gender (N) and BMI category (%).
bp from ANOVA except for Gender and BMI category (Chi square).
cAdjusted for Gender and Age tertile.
dBMI ,25 (Normal), 25–29.9 (Overweight), $30 (Obese) kg/m2.
doi:10.1371/journal.pone.0070435.t001
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persistent shared (C) and individual (E) environmental components
[26]. E includes all error variance. Gene-environment interactions
are clearly important for the expression of increased adiposity but
are difficult to quantify and their presence degrades the ability of
genetic analyses to isolate both gene and environmental effects.
The increase in prevalence of overweight and obesity over the last
half century is too large and too rapid to be due to changes in the
gene pool and must somehow reflect the effect of deleterious
environmental influences [1]. However, current data suggest that
the prevalence of obesity is plateauing in some highly developed
countries, including Australia [27,28], consistent with the notion
that the full expression of genetic susceptibility is being
approached in the worst affected populations. Under such
circumstances, gene-environment interactions have permitted
increasing expression of underlying genetic susceptibility and the
interactions will collapse towards pure gene effects [29], simpli-
fying the analysis of genetic data. We therefore assume that the
effects of gene-environment interactions are saturated in our data
and that the effects of FH can be represented as the sum of the A
or D and C components.
Because of the close association between T2DM and increased
adiposity, a family history of T2DM represents the sum of genetic
and persistent shared environmental influences on T2DM risk and
on risk of increased adiposity. Although the effects of any persistent
shared environmental influences have been difficult to quantify,
the relevant literature consistently demonstrates that those
influences are negligible on traits related to body composition or
T2DM: ie studies of Body Fat% [30] and BMI [31–33] in twins,
BMI [34] and T2DM [35] in adoptees and in appetite-related
traits in children [36]. Hence, in the current context, the effects of
family history can be interpreted as predominantly genetic. The
total trait variance is therefore modelled as A or D + E, and
heritability (h2) is obtained from:
h2~1{e2
where e2 is the proportion of error variance in the models
incorporating FH effects.
Under these assumptions, a heterogenetic model of inheritance
predicts segregation of traits in families [5] and we therefore
analysed and compared the distributions of traits in the FH+ and
FH2 groups.
Statistical methods. All analyses were performed using R
2.12.1 [37].
Effects of Age (as tertiles) and Gender were assessed by two-way
ANOVA. No significant interactions between age and gender
were detected in any models (p.0.35). BMI was analysed after
Log-transformation to correct markedly skewed residuals.
Two orthogonal (uncorrelated) factors were extracted from the
log-transformed anthropometric (height, waist and hip circumfer-
ences) and body composition (lean, bone and fat masses) data
using the factanal function in R with varimax rotation. This
procedure produces the most parsimonious orthogonal factors.
The input variables were log-transformed to accommodate the
geometric relationships between measurements in one linear
dimension (height and circumferences) and those in 3 dimensions
(masses, which are related to volumes) [21]. Predicted individual
scores (SD units) on the factors were calculated using Bartlett’s
method in factanal.
Effects of a family history of T2DM (FH+, FH2) were assessed
initially by three-way ANOVA (Gender + Age tertile + FH). No
significant two-way interactions were detected in any models
(p.0.13). Further analyses of FH effects were conducted on
variables adjusted for the effects of gender and age (coded and
presented as residuals from Gender + Age tertile models). Effects
of FH were also assessed by comparing distributions of Gender-
and Age-adjusted variables between FH+ and FH2 groups:
variables were binned by deciles of the full sample and relative
risks (RR, FH+/FH2) of occurrence in each decile were
calculated as pi(FH+)/pi(FH2) where pi = ni/N, ni = individuals
in the ith decile and N = individuals per group; 95% confidence
intervals were obtained from the standard error of log(RR)
assuming normality.
Gender- and Age-adjusted variables were fitted to bimodal
normal distributions using the optim function in R. Data were
binned by deciles of the full sample and bin densities were fitted to
the model:




















where: y = predicted density of the bimodal model at the mid-
point of each decile of x, x = empirical density at the mid-point of
each decile, m1 = mean of the lower mode, d2 = positive
difference between the means of the two modes, s = standard
deviation, a = fraction of the total density accounted for by the
upper mode.
a was constrained to the interval 0–1, as was d2 to $0, using the
L-BFGS-B method in optim. Heritability (h2) was calculated
as 1-s2.
An estimate of the fraction of FH2 individuals in the upper




where a FH2 and aFH+ are respectively the fractions of the FH2
and FH+ groups under the upper mode, and RR8 is the relative
risk ratio (FH+/FH2) in the 8th decile of the full distribution.
Risk variant frequencies in FH2 and FH+ groups, were
calculated from the phenotypic proportions (aFH2 and aFH+)
under a dominant bi-allelic model of inheritance assuming Hardy-
Weinberg equilibrium [38]. In this model, genotype frequencies
(AA, Aa, aa) are related to allele frequencies (p, q) through the
relationships AA = p2, Aa = 2pq, aa = q2, where a and q represent





Risk variant and genotype frequencies in the unobserved
T2DM-affected family members were calculated assuming that




95% confidence intervals for parameter estimates and derived
frequencies were obtained by bootstrap re-sampling (NFH2 = 122+
NFH+ = 80, 1000 draws).
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Results
Participants with (FH+) and without (FH2) a family history of
T2DM were well matched for age and gender (Table 1). After
adjustment for the age and gender effects illustrated in Table 2, the
FH+ group had significantly higher percentage body fat (Body
Fat%), fat mass and waist circumference, with borderline higher
hip circumference and continuous and categorical BMI (Table 1).
The two factors extracted from the anthropometric and body
composition data (Frame and Adiposity) accounted for 80% and 95%
of the standardised variance and covariance respectively in the
input variables and provide a readily interpretable summary of the
data. The loading pattern of the input variables on the two factors
(Fig. 1) suggests Frame and Adiposity as appropriate names for the
factors. Frame displays the expected large effect of gender, but no
effect of age (Table 2). Adiposity was not affected by gender in this
sample but increased significantly with age (Table 2). After
adjustment for age and gender Frame was not affected by FH but
Adiposity was significantly higher in FH+ (Table 1). Adiposity
correlated strongly and equally well with Body Fat % (r = 0.91)
and log-transformed BMI (r = 0.93) (all adjusted for age and
gender).
The distributions of the measures of adiposity (Adiposity, Body
Fat%, log-transformed BMI) and Frame in FH+ and FH2 groups
are compared in Fig 2. Compared to FH2, FH+ distributions for
the adiposity measures show a localised excess density around the
8th decile, consistent with bimodality, which was most apparent in
Adiposity; Frame was distributed similarly in the two groups. The
relative risks of occupancy of the deciles (Fig 2 I–L) illustrate this
pattern, with localised enrichments of FH+ in the 8th decile of
Adiposity (RR 3.6 95%CI 1.4, 8.9) and Body Fat %, (3.6 1.4, 8.9), a
similar tendency in log-transformed BMI (2.3 1.0, 5.4) and no
significant enrichment in any decile of Frame. Fits to a bimodal
distribution identified a 2nd mode only in the Adiposity data from
FH+ (Fig 2A, Fig 3), with the distance between modes of 0.93
(95%CI 0.07, 1.45) SD units and an estimated 59% (95%CI 40%,
74%) of individuals under the upper mode (a, Fig 3). Heritability
of age- and gender-adjusted Adiposity calculated from the standard
deviation was 91% (31%, 96%); when expressed in terms of
unadjusted Adiposity by including the contributions of age and
gender (R2 = 0.12) the estimate was 80% (27%, 84%).
The bimodal distribution of Adiposity in FH+ is consistent with
dominant expression of susceptibility variants in a bi-allelic system.
Table 3 shows the estimated phenotypic proportions (a) and risk
allele frequencies (q) in FH2, FH+ and the unobserved T2DM-
affected family members, assuming dominance and Hardy-
Weinberg equilibrium. The analysis predicts that approximately
85% of the T2DM individuals carry a dominantly-expressed
genetic risk of increased adiposity.
Table 2. Anthropometry, body composition, Frame and Adiposity factor scores by gender and age tertile. Mean 6 SD.
Gender Female Male
Age Tertile 1 2 3 1 2 3 ANOVA effects (p)a
n 41 44 36 25 26 30 Gender Age
Age (y) 27.565.0 43.964.8 60.065.4 29.562.9 42.764.6 61.365.1 0.30 –
Height (m) 1.6660.07 1.6360.06 1.6160.06 1.7960.06 1.7960.08 1.7660.07 ,0.0001 0.0007
Waist (cm) 75610 81612 88614 85610 96610 100614 ,0.0001 ,0.0001
Hip (cm) 9869 102613 105611 9968 10266 10469 0.88 0.001
Body weight
(kg)
66.3612.4 67.8614.0 71.6614.2 79.0613.2 85.7613.9 86.3618.5 ,0.0001 0.11
Lean mass (kg) 39.963.8 39.264.6 39.864.2 58.866.7 57.567.3 58.467.9 ,0.0001 0.90
Bone mass (kg) 2.760.3 2.560.3 2.460.3 3.360.5 3.260.4 3.160.5 ,0.0001 0.004
Fat mass (kg) 24.2610.3 26.3611.3 30.0611.8 17.768.7 25.868.8 26.1612.6 0.02 0.02
BMI (kg/m2)b 24.364.3 25.665.6 28.165.6 24.863.4 26.8641. 28.165.8 0.35 0.001
Body fat (%) 34.968.2 37.269.8 40.368.6 21.367.7 29.266.4 28.468.4 ,0.0001 0.006
Frame (SD units) 20.6460.40 20.7660.50 20.7560.44 1.2060.51 0.9860.54 1.0460.56 ,0.0001 0.32
Adiposity (SD units) 20.2460.89 0.0561.14 0.4560.97 20.7161.01 0.1660.74 0.1861.05 0.14 0.003
aNo significant Gender*Age interactions (all p.0.35).
bAnalysed after log-transformation.
doi:10.1371/journal.pone.0070435.t002
Figure 1. Loading pattern of log-transformed body size and
composition variables on the ‘Frame’ and ‘Adiposity’ factors. The
loadings are the correlation coefficients between the input variables
and the extracted factors.
doi:10.1371/journal.pone.0070435.g001
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Discussion
Summary
In our sample approximately half of the individuals with a 1st
degree family history of T2DM (FH+) manifest a susceptibility to
increased adiposity. This is consistent with the greater weight gain
of FH+ drawn from the same population during voluntary over-
feeding [8], and with previous reports of association between FH+
and increased BMI [6,7]. We conclude that this genetic
susceptibility to increased adiposity is mediated at least in part
by behavioural responses to food-related signals, consistent with
the likely effects of the known obesity-related genetic variants [9].
The distribution of Adiposity in FH+ is not consistent with the
predictions of a polygenic model but conforms to a heterogenetic
model of dominant expression of rare susceptibility variants with
large effects. The predicted 86% of unobserved T2DM individuals
carrying these variants is close to the estimated 80–90%
prevalence of overweight/obesity in T2DM [2]. We hypothesise
that most or all of the overweight/obesity in T2DM is due to a
dominantly expressed genetic susceptibility to increased adiposity.
The same mechanism could account for a substantial fraction of
endemic obesity.
Figure 2. Distributions of gender- and age-adjusted body composition variables. A–D: FH+; E–H: FH2; I–L: relative risks of occurrence
(with 95%CI) in each decile of the distributions of body composition variables (FH+/FH2) The dotted line in panel A represents the fit to a bimodal
normal distribution.
doi:10.1371/journal.pone.0070435.g002
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Segregation and mode of inheritance of increased
Adiposity
Many previous studies have detected evidence of segregation
and/or multimodality of adiposity-related traits but the inferred
modes of inheritance have varied. Early studies (reviewed in Price
et al [39]) found evidence of recessive expression of higher
adiposity, while more recent studies have tended to favour
dominant or additive models of expression. As argued by Price
et al [39], part of this variation may be may be due secular trends
in gene-environment interactions which have the effect of
simulating recessive inheritance in multi-generational studies.
The use of extreme obesity phenotypes would also tend to favour
a recessive pattern if the true mode is additive and the
heterozygous phenotype is either obscured by definition [40] or
is indistinguishable in the data [41,42]. Finally, very large sample
sizes are required to reliably detect dominance effects and some
recessive findings are likely to be due to lack of power to detect
other modes of inheritance [43]. In summary, published studies
are not inconsistent with our interpretation of dominant or
additive expression of genetic susceptibility to increased adiposity
and some reports provide explicit support for it [39,44–47].
The bimodal distribution of Adiposity in FH+ is consistent with
segregation in families of obesity susceptibility variants with major
effects, in contrast to the predictions of a polygenic model in which
variants at many loci have cumulative small effects on the
phenotype. Previous studies of the transmission of obesity-related
phenotypes have also generally not favoured the polygenic model.
The inability of common SNVs to account for more than a small
fraction of the heritability of increased adiposity in GWAS implies
that the variants responsible for segregation must have escaped
detection and are therefore either rare, or are not closely linked to
the common SNVs targeted in GWAS, or both. While GWAS
have not targeted copy number variations (CNVs), a recent study
of linkage-disequilibrium between common SNVs and common
CNVs has concluded that ‘‘..for complex traits, the heritability
void left by genome-wide association studies will not be accounted
for by common CNVs.’’ [14]. Our analysis is insensitive to the
nature of the inherited variations but we can conclude that they
must be rare to have escaped detection in large scale studies, and
must have large effects to account for the separation between
modes of Adiposity (0.93 SD). It may be that a large number of
dominantly-expressed risk variants with large effects will be easier
to work with than the polygenic alternative, especially if the effects
are clustered within a limited number of pathways [48], such as
those involved in the regulation of feeding behavior [9].
Phenotypes
The Adiposity factor showed a clearer pattern of responses to the
explanatory variables in this analysis than did the alternative
measures of body fatness. Although Adiposity correlated strongly
and equally well with Body Fat % and log-transformed BMI it can
be expected to provide more clarity for two reasons. First, factor
extraction eliminates uncorrelated components of the input
variables, which can result in a reduction in error variance and
hence in more statistical power. Second, no assumptions were
made about the structure of the factor, except for the log-
transformation of the inputs to accommodate the dimensional
relationships between them [21], and Adiposity may therefore
reflect more accurately the biology of fat stores. The clear loading
pattern of y-variables on the two factors which leads naturally to
their interpretation as Frame and Adiposity, and the isolation of
segregation behavior to Adiposity give support to the biological
validity of the factors.
In a comparable study Tayo et al [46] analysed a collection of 7
raw obesity-related phenotypes including BMI, BSA, fat mass and
%fat, extracting two factors, both of which showed evidence of
segregation in families with dominant or additive expression. As
the structures of the factors could not be interpreted biologically,
the authors concluded that they represent different genetic variants
with pleiotropic effects on obesity-related traits. More likely
however their factor structures are a product of the inappropriate
choice of phenotypes for the analysis, resulting in a correlation
structure which violates key requirements for the extraction of
reliable and interpretable factors. For example BMI and BSA are
both calculated from height and weight, and fat mass and fat%
both contain the same primary measurement; inclusion of both
members of each pair could cause severe multi-collinearity, as
found in our data if analysed in that way (not shown). In addition
all of Tayo et al ’s obesity-related variables are either surrogates or
arbitrary constructs unlikely to relate directly to underlying
biology, and fat mass contains a component related to body size
for which there is no clear marker amongst the variables. We can
reproduce the results of Tayo et al [46] as they relate to dominant
or additive expression of segregating obesity susceptibilities but,
through a more rigorous approach to phenotype construction, we
provide a simpler, biologically plausible explanation. Adiposity
appears to capture more accurately the biology of fat stores and to
Figure 3. Quantile boxplots representing the median, inter-
quartile range and 95% confidence limits of the parameters of
the bimodal distribution model obtained from the Adiposity
data in FH+ by bootstrap re-sampling. m1 = mean of the lower
mode; d2 = difference between the means of the 2 modes; s =
common standard deviation; a = the fraction of individuals in the
higher distribution. The open circles are the estimates from the original
data.
doi:10.1371/journal.pone.0070435.g003
Table 3. Phenotypic proportions (a) and estimated risk allele
frequencies (q) in FH2, FH+ and unobserved T2DM-affected
family members under a dominant model of inheritance of
Adiposity.
FH2 FH+ T2DMa
ab 0.16 (0.04, 0.41) 0.59 (0.40, 0.74) 0.85 (0.60,0.98)
qc 0.09 (0.02, 0.23) 0.36 (0.22, 0.48) 0.62 (0.36, 0.88)
Presented as median (95% CI).
acalculated from q FH2 and qFH+ assuming that the FH2 group represents the
pool of spouses in the parental generation.
bFraction of individuals under the higher Adiposity mode.
ccalculated assuming a dominant bi-allelic model of inheritance in Hardy-
Weinberg equilibrium.
doi:10.1371/journal.pone.0070435.t003
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be more genetically informative than the other traits analysed
here. It is likely that in genetic studies the increased cost of more
accurate phenotyping compared to cheaper surrogate measures
would be more than compensated for by the decreased sample size
required and by the increased clarity of the results.
Relationship to overweight/obesity
The estimated proportion of FH2 with the high Adiposity
phenotype (16%), and by implication carrying the risk alleles, is
equivalent to the proportion of obese (BMI$30) individuals in the
group (15%). While we did not find explicit statistical support for
the presence of multiple modes within our FH2 data, previous
studies of BMI in much larger samples have detected multiple
modes (2 or 3) in different populations, with proportions in the
higher modes well within our confidence interval [49,50]; both
studies supported an interpretation of environmentally determined
expression of genetic susceptibilities due to major gene effects at
the population level. Our result in FH2 is also consistent with this
interpretation, and together with the segregation of the high
Adiposity phenotype in FH+ suggests that rare dominantly-
expressed risk variants may account for a large fraction of the
highly prevalent obesity in non-diabetic as well as diabetic
humans.
Relationship to T2DM
The predicted 85% of unobserved T2DM individuals carrying
these variants is close to the estimated 80–90% prevalence of
overweight/obesity in T2DM [2]. We conclude that most if not all
of the overweight/obesity in T2DM is due to a dominantly
expressed genetic susceptibility to increased adiposity. The
understanding that subjects who will develop T2DM carry a
strong genetic predisposition to increased weight gain as part of
the inheritance [8] could do much to alleviate the blame and guilt
currently associated with the weight gain in such people and
sharpen the focus on early preventative and therapeutic interven-
tions. The pathological impact of such obesity is underlined by its
strong association with T2DM and its major metabolic compli-
cations.
The relationship between the Adiposity variants and the T2DM
susceptibility variants also present in FH+ is unclear, in part
because the mode of inheritance of T2DM susceptibility is unclear.
The results of GWAS imply that with few exceptions (eg FTO
[51]) T2DM susceptibility is inherited independently of obesity
susceptibility and under those conditions, and assuming a
heterogenetic model of T2DM genetics, approximately 30%
(0.5960.5) of our population of FH+ would be at high risk of
developing T2DM in their current environment. However as the
currently identified SNPs from GWAs represent only a small
fraction of the total heritability of both T2DM and obesity they
may be unrepresentative and some unknown fraction of shared
inheritance (ie pleiotropy) may be involved. In support, a linkage
study, which unlike GWAS could detect rare susceptibility
variants, found suggestive evidence of pleiotropic inheritance in
6 of 12 loci identified [52]. With full pleiotropy approximately
60% (59%) of the FH+ would be at high risk of developing T2DM.
We therefore estimate that FH+ confers between 30% and 60%
risk of developing T2DM in this population and environment.
Concordance rates of T2DM in DZ twins, who share the same
fraction of genes as do 1st degree relatives, range from 3% to 71%
[32,53–57], but interpretation is complicated by marked variation
in age at disease onset and study ascertainment of disease, and by
possible effects of twin status on T2DM risk [57].
Clinical and public health implications
In a society where the current belief is that voluntary
‘‘overeating’’ leads to weight gain in the majority of people who
develop T2DM, the understanding that excess weight is a genetic
disorder linked with the T2DM would lift a burden of guilt from
the patient and allow earlier targeted therapy. If, as we suggest,
similar mechanisms are responsible for a large part of endemic
obesity this ought to inform clinical and public health interven-
tions.
Assumptions & limitations
This is a moderate sized and probably ethnically diverse sample
recruited primarily to detect any underlying abnormalities in
healthy T2DM relatives and therefore it may not adequately
represent the population from which it was drawn, or other
populations. Obese subjects (BMI$30 kg/m2) are under-repre-
sented in the FH2 group (15%) compared to the population of the
state of New South Wales (28% [58]), which could reflect the
characteristics of the sub-population sampled from and/or the
selection criteria used in the studies which provided our data. The
moderate sample size is reflected in the wide confidence intervals
around some estimates. Replication of the findings in larger
samples and with appropriate sampling strategies is indicated.
The interpretation of family history as a purely genetic effect
depends on the assumption that persistent effects of shared family
environment are negligible in this context. If this assumption is
false it would lead to an overestimation of genetic effects in the
data. However many well-powered studies have found negligible
(if any) effects of shared environment on traits related to body
composition or T2DM (see Methods). While we cannot exclude a
small contamination of genetic effects with those due to shared
environment, published direct evidence demonstrates a predom-
inantly genetic influence of family history in this context.
We also assume that obesogenic environmental influences are
saturating in our and similar populations, exposing genetic
susceptibilities and permitting an analysis which ignores gene-
environment interactions. Violation of this assumption would lead
to an underestimation of genetic susceptibility. The apparent
plateauing of BMI trends in children in developed countries has
two plausible, non-exclusive explanations [27]: the intervention
hypothesis, which assigns some of the trend to public health
campaigns and interventions, and the saturation equilibrium
hypothesis which we assume. While some component due to
intervention cannot be excluded, it is unlikely to be a major
contributor given the minimal effects so far of recent public health
interventions directed at obesity [59]. Moreover, the increase in
genetic variance across levels of adiposity seen in a large sample of
twins is consistent with greater expression of obesity-susceptibility
genes in more obesogenic environments [29].
Within the genetic model of FH, accepting the segregation of
Adiposity and its implications for susceptibility variant frequencies,
we find little missing genetic effect. Hence we conclude that our
analysis supports the saturation equilibrium hypothesis as an
explanation for plateauing BMI trends in this and other developed
countries [27].
The calculation of risk allele and genotype frequencies in the
unobserved T2DM-affected family members is based on three
additional assumptions: 1) that the FH2 group represents the
spouse population, 2) that there is random mating in relation to
obesity susceptibility between T2DM and spouses and 3) that
relative risk ratios reflect accurately the relative proportion of
individuals under the higher Adiposity mode in FH+ and FH2. The
calculations are not in fact very sensitive to plausible violations of
the 1st assumption; e.g. if we replace our estimate of a FH2 (0.16)
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with the proportion of obese subjects in the New South Wales state
population (0.28) assuming a proportionate change in allele
frequency, the estimate of aT2DM is only marginally reduced
(from 0.86 to 0.80). The 2nd assumption is supported by very low
published estimates (,2% of variance) of the contribution of
assortative mating to transmission of obesity susceptibility [43,60].
The 3rd assumption implies that Adiposity in FH- has the same
distributional characteristics as in FH+, which is supported by the
large-scale studies previously cited [49,50].
Conclusion
Our analysis supports the hypothesis that genetic susceptibility
to increased adiposity in T2DM, and perhaps more generally, is
predominantly the result of a large number of rare genetic variants
with large effects. Although our conclusions are dependent on
assumptions, the most important assumptions are well supported
by the literature. Clearly these findings must next be replicated in
different groups, but meanwhile they strongly suggest a need for a
change in approach to gene discovery in T2DM and obesity, to
one which places more emphasis on accurate phenotyping and
family studies, aims to pool the effects of closely-related rare
variants in analyses, and which places more weight on the
biological plausibility of proposed links to disease processes [61].
The potential reward is that results may then offer a rational basis
for targeting therapy in a manner not yet possible.
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